avsa

Get ready for a live demo TOMORROW covering the latest changes to the BIOS AI Scientist.

🦞 Agent Builders: Check out the new BIOS API and learn how to add scientific intelligence to your agent.

🧪 Researchers: See how to make the most of BIOS interactive deep research runs.

Secure your spot ↓

Bio AI Lab

There are only 2 HOURS remaining before we demonstrate BIOS, our newly created general-purpose AI scientist. During the broadcast, @SynBio1 and the Bio AI team will engage in real-time biomedical research utilizing scientific agents. You are invited to observe the way researchers employ BIOS to execute their investigations. Please submit your RSVP here.

The Bio AI team invites you to a live demonstration tomorrow featuring BIOS, our newly developed AI Scientist. @SynBio1, a synthetic biologist formerly with Ginkgo Bioworks, will participate in live interactive research runs. Tune in to observe how BIOS serves to accelerate biomedical discovery.

RSVP below

Tomorrow, we are hosting a live demonstration of BIOS, our new AI Scientist. Synthetic biologist and ex-Ginkgo Bioworks expert @SynBio1 joins the Bio AI team for live interactive research runs. Tune in to see how BIOS accelerates biomedical discovery. RSVP below.

Percepta by @Cerebrum_DAO has successfully received IRB approval to move forward with human trials. This initiative involves a 6-month decentralized study that is randomized, double-blinded, and placebo-controlled. The trial framework features the integration of wearable data alongside neurocognitive assessments for processing speed, memory, and cognitive function. Additionally, the study will track P-tau 217, which is currently the leading blood-based biomarker for cognitive decline.

A New Perspective on the AI Scientist: Utilizing BIOS and Interactive Multi-Agent Workflows for Scientific Discovery

Notre diffusion en direct commence dans 2 HEURES avec @AakaashMeduri, @lukasweidener, @paulkhls, @cl2pp, et l'équipe Bio AI. Nous nous concentrerons sur BIOS, notre nouveau scientifique en IA développé pour gérer des tâches de recherche biomédicale complexes grâce à l'orchestration de sous-agents scientifiques spécialisés. Veuillez vous inscrire via le lien ci-dessous.

Empowering a Scientific Intelligence Economy through BIOS

When laboratories and research professionals engage with BIOS for intricate biomedical investigations, they operate on a pay-per-query basis. These inquiries are distributed to specific subagents, each possessing expertise in distinct domains or research functions. For every useful contribution provided during this process, these subagents are compensated directly through the x402 payments protocol.

Picture an ecosystem populated by hundreds of these specialized digital entities, covering fields ranging from drug interactions and rare diseases to computational chemistry and cancer genomics. A true Agents GDP is created as these units vie for dominance in their respective fields, earning revenue based on the quality of their output. Financial value flows directly to the intelligence that successfully produces results.

This dynamic establishes a powerful positive feedback loop. As subagents strive for best-in-class status, the network's overall intelligence deepens, attracting a higher volume of researchers to the platform. Consequently, the circulation of $BIO increases, boosting the system's total value. This growth incentivizes developers to construct additional subagents, starting the cycle anew.

Explore the links below to discover more and experience BIOS firsthand.

We are inviting all scientists and AI researchers to tune in TODAY for the livestream debut of BIOS. Distinguished as the #1 ranked system on global benchmarks, this new AI Scientist is built specifically for interactive biomedical research. The @BioAIDevs group will be on hand to discuss the model and conduct a live demo regarding the use of the BIOS interface for scientific R&D.

RSVP ↓

FolliCool Shampoo developed by @HairDAO_ has officially arrived on the Biofy platform. Based on community studies, this formula is designed to ensure your hair feels voluminous while maintaining a calm scalp. Make sure to utilize the code BIOFY10 at checkout to secure a 10% discount. As an added perk, you will receive a 5K BioXP bonus with every order. Access the link below to purchase your FolliCool.

Please join us this THURSDAY for a livestream to unveil a new agentic science product designed for researchers.

We will also share a major milestone from our AI for Science lab and dive into our open-source framework for building scientific agents.

What will you discover?

RSVP below ↓

"""
Investir, éduquer, mettre en œuvre.

Bio développe des infrastructures pour améliorer la transition de la science biomédicale vers des applications pratiques :

• Bio Protocol : financer la recherche, favoriser les communautés, passer du laboratoire au marché
• BioAgents : des scientifiques alimentés par l'IA identifient des solutions efficaces, leurs démographies cibles et les raisons sous-jacentes
• Biofy : un cadre commercial qui transforme la recherche en produits tangibles, prêts pour le marché

Infrastructures numériques pour un avancement scientifique accéléré.

Passer du laboratoire au consommateur à un coût et une vitesse significativement réduits.

Livrer des innovations scientifiques d'ici 2026.
"""

12 Jours des Gagnants de DeSci Yapping (24 déc) 🎄

La distribution de BioXP à nos gagnants quotidiens a été complétée, et elle sera applicable pour la prochaine vente de $SKIN prévue pour début janvier.

Il ne reste que 4 jours avant que l'XP pour DeSci yapping ne se termine.

Si votre nom d'utilisateur apparaît dans la liste ci-dessous, veuillez prendre un moment pour vérifier votre portefeuille sur l'Application Bio ↓

"""
MAINTENANT EN STREAMING !

Nous sommes ravis de partager les mises à jour les plus récentes sur Biofy, les lancements presque épuisés de Moon + Sol de @dermadao, et la vente à venir de $SKIN.

Participez à la conversation :
"""

Métriques HOLI Post-TGE ⬇

Évaluation initiale : 500 000 $
Évaluation la plus élevée : 5,2 millions $
Multiple atteint : environ 10x dans les conditions de marché actuelles
Volume cumulé : 290 000 $
Nombre de participants : plus de 400

Prix environ deux heures plus tard : stabilisé autour de 3,5 millions $

Dans un paysage où le capital d'investissement est exigeant, cela démontre un niveau de confiance fort—non seulement dans $HOLI, mais aussi dans le secteur DeSci au sens large.

HOLI a réussi à atteindre son objectif de financement minimum !

→ Plus de 100K USDC ont été promis par plus de 400 contributeurs
→ Il ne reste que quelques heures pour participer
→ La vente se termine AUJOURD'HUI à 15h UTC

C'est votre dernière opportunité de contribuer USDC & BioXP : https://app.bio.xyz/ipts/holi